San Francisco Bay Area biotech stories.
Thursday, March 24, 2011
AcelRx loses $3.5 million in Q4, $14.3 million in 2010
AcelRx Pharmaceuticals Inc. lost $3.5 million in the December quarter and $14.3 million in 2010.
The Redwood City company (NASDAQ: ACRX) lost $3.7 million in the fourth quarter of 2009.
Share to Twitter
Share to Facebook
Post a Comment
Post Comments (Atom)